Published in J Pharmacol Exp Ther on August 01, 1985
Cellular and molecular toxicity of lead in bone. Environ Health Perspect (1991) 1.80
Intracellular compartmentation of metals in aquatic organisms: roles in mechanisms of cell injury. Environ Health Perspect (1987) 0.95
Effects of lead on the kidney: roles of high-affinity lead-binding proteins. Environ Health Perspect (1991) 0.91
Roles of lead-binding proteins in mediating lead bioavailability. Environ Health Perspect (1998) 0.84
Mechanisms of kidney cell injury from metals. Environ Health Perspect (1993) 0.80
Lead-binding proteins: a review. J Toxicol (2011) 0.79
Metal constitution of metallothionein influences inhibition of delta-aminolaevulinic acid dehydratase (porphobilinogen synthase) by lead. Biochem J (1987) 0.79
Isolation and partial characterization of a cadmium-binding protein from the American oyster (Crassostrea virginica). Chem Biol Interact (1979) 1.43
TCDD-induced changes in rat liver microsomal enzymes. Environ Health Perspect (1973) 1.24
Metallothionein and other cadmium-binding proteins: recent developments. Chem Res Toxicol (1992) 1.22
Bisphenol A-induced increase in uterine weight and alterations in uterine morphology in ovariectomized B6C3F1 mice: role of the estrogen receptor. Toxicol Sci (2000) 1.14
Ultrastructural and biochemical effects of prolonged oral arsenic exposure on liver mitochondria of rats. Environ Health Perspect (1977) 1.12
Occupational lead exposure, nephropathy, and renal cancer. Am J Ind Med (1980) 1.12
Arsine poisoning. N Engl J Med (1974) 1.09
Early cellular effects of circulating cadmium-thionein on kidney proximal tubules. Environ Health Perspect (1979) 1.07
Effects of arsenic on pyruvate dehydrogenase activation. Environ Health Perspect (1977) 1.06
Mercury uptake by renal lysosomes of rats ingesting methyl mercury hydroxide. Ultrastructural observations and energy dispersive x-ray analysis. Arch Pathol (1974) 1.05
The morphological effects of chronic cadmium administration on the renal vasculature of rats given low and normal calcium diets. Toxicol Appl Pharmacol (1975) 1.03
Interaction of copper with DNA and antagonism by other metals. Toxicol Appl Pharmacol (1991) 1.01
Mechanisms of nephrotoxicity from metal combinations: a review. Drug Chem Toxicol (2000) 1.00
High-affinity lead binding proteins in rat kidney cytosol mediate cell-free nuclear translocation of lead. J Pharmacol Exp Ther (1985) 0.99
Intracellular binding of lead in the kidney: the partial isolation and characterization of postmitochondrial lead binding components. Biochem Biophys Res Commun (1982) 0.96
Effects of lead on the heme biosynthetic pathway in rat kidney. Exp Mol Pathol (1985) 0.96
Purification and characterization studies of cadmium-binding proteins from the American oyster, Crassostrea virginica. Environ Health Perspect (1986) 0.95
Isolation and partial characterization of a high molecular weight Cd/Zn-binding protein from the kidney of the scallop Placopecten magellanicus: preliminary studies. Environ Health Perspect (1986) 0.95
Altered subcellular distribution of cadmium following cadmium pretreatment: possible mechanism of tolerance to cadmium-induced lethality. Toxicol Appl Pharmacol (1983) 0.95
Chronic low-level lead toxicity in the rat. III. An integrated assessment of long-term toxicity with special reference to the kidney. Toxicol Appl Pharmacol (1980) 0.95
Alteration in protein synthesis in primary cultures of rat kidney proximal tubule epithelial cells by exposure to gallium, indium, and arsenite. Toxicol Appl Pharmacol (1990) 0.95
The effects of chronic oral methyl mercury exposure on the lysosome system of rat kidney. Morphometric and biochemical studies. Lab Invest (1975) 0.95
Intracellular compartmentation of metals in aquatic organisms: roles in mechanisms of cell injury. Environ Health Perspect (1987) 0.95
In vivo X-ray fluorescence of lead in bone. Environ Res (1992) 0.94
The transplacental toxicity of methyl mercury to fetal rat liver mitochondria. Morphometric and biochemical studies. Lab Invest (1977) 0.94
Effects of chronic arsenic exposure on hematopoietic function in adult mammalian liver. Environ Health Perspect (1977) 0.94
Influence of metal ions on renal cytosolic lead-binding proteins and nuclear uptake of lead in the kidney. Biochem Pharmacol (1986) 0.93
Ultrastructural and biochemical changes in renal mitochondria during chronic oral methyl mercury exposure: the relationship to renal function. Exp Mol Pathol (1977) 0.93
The morphologic effects of dieldrin and methyl mercuric chloride on pars recta segments of rat kidney proximal tubules. Am J Pathol (1972) 0.93
The renal toxicity of cadmium metallothionein: morphometric and X-ray microanalytical studies. Toxicol Appl Pharmacol (1978) 0.92
Ruthenium red staining of rat glomerulus. Perfusion of ruthenium red into normal and nephrotic rat kidney. Histochemie (1970) 0.91
Bismuth localization within nuclear inclusions by x-ray microanalysis. Effects of accelerating voltage. J Histochem Cytochem (1975) 0.91
Studies on the action of porphyrinogenic trace metals on the activity of hepatic uroporphyrinogen decarboxylase. Biochem Biophys Res Commun (1981) 0.90
Concurrent exposure to lead, cadmium, and arsenic. Effects on toxicity and tissue metal concentrations in the rat. J Lab Clin Med (1981) 0.89
Ultrastructural evidence for nephropathy induced by long-term exposure tosmall amounts of methyl mercury. Science (1972) 0.89
Alteration of hepatic microsomal structure and function by indium chloride. Ultrastructural, morphometric, and biochemical studies. Lab Invest (1983) 0.89
Regulation of lead inhibition of delta-aminolevulinic acid dehydratase by a low molecular weight, high affinity renal lead-binding protein. J Pharmacol Exp Ther (1984) 0.89
Introduction and summary. International workshop on lead in bone: implications for dosimetry and toxicology. Environ Health Perspect (1991) 0.89
Factors influencing cadmium accumulation and its toxicity to marine organisms. Environ Health Perspect (1979) 0.88
High-affinity renal lead-binding proteins in environmentally-exposed humans. Chem Biol Interact (1998) 0.87
Cadmium-Metallothionein nephropathy: relationships between ultrastructural/biochemical alterations and intracellular cadmium binding. J Pharmacol Exp Ther (1984) 0.86
Renal porphyrinuria during chronic methyl mercury exposure. J Lab Clin Med (1977) 0.86
Tissue distribution and histopathological effects of titanium dioxide nanoparticles after intravenous or subcutaneous injection in mice. J Appl Toxicol (2011) 0.86
Lead inhibits secretion of osteonectin/SPARC without significantly altering collagen or Hsp47 production in osteoblast-like ROS 17/2.8 cells. Toxicol Appl Pharmacol (1992) 0.86
Alteration of hepatocellular structure and function by thallium chloride: ultrastructural, morphometric, and biochemical studies. Toxicol Appl Pharmacol (1986) 0.86
Role of sulfhydryls in the hepatotoxicity of organic and metallic compounds. Fundam Appl Toxicol (1985) 0.86
Effects of concurrent administration of lead, cadmium, and arsenic in the rat. Environ Health Perspect (1977) 0.85
Long-term turnover of cadmium metallothionein in liver and kidney following a single low dose of cadmium in rats. Biochim Biophys Acta (1981) 0.85
A low molecular weight lead-binding protein in brain attenuates lead inhibition of delta-aminolevulinic acid dehydratase: comparison with a renal lead-binding protein. J Pharmacol Exp Ther (1986) 0.85
Effects of separate and combined chronic mercuric chloride and sodium selenate administration in rats: histological, ultrastructural, and x-ray microanalytical studies of liver and kidney. J Environ Pathol Toxicol (1979) 0.85
Interactions among lead, cadmium, and arsenic in relation to porphyrin excretion patterns. Environ Health Perspect (1978) 0.85
Preliminary purification and characterization studies of a low molecular weight, high affinity cytosolic lead-binding protein in rat brain. Biochem Biophys Res Commun (1989) 0.84
Urinary biomarkers to detect significant effects of environmental and occupational exposure to nephrotoxins. IV. Current information on interpreting the health implications of tests. Ren Fail (1997) 0.84
Production of low molecular weight cadmium-binding proteins in rabbit lung following exposure to cadmium chloride. Biochem Pharmacol (1982) 0.84
Effects of the herbicide paraquat on the ultrastructure of mouse kidney. Am J Pathol (1971) 0.83
Effects of beta-estradiol and bisphenol A on heat shock protein levels and localization in the mouse uterus are antagonized by the antiestrogen ICI 182,780. Toxicol Sci (2001) 0.83
Renal metabolism and toxicity of metallothionein. Dev Toxicol Environ Sci (1982) 0.83
Regulatory roles of high-affinity metal-binding proteins in mediating lead effects on delta-aminolevulinic acid dehydratase. Ann N Y Acad Sci (1987) 0.83
Age-related differences in susceptibility to cisplatin-induced renal toxicity. J Appl Toxicol (2010) 0.82
Ultrastructural changes in rat liver cells following a single oral dose of TCDD. Environ Health Perspect (1973) 0.82
Evidence for oxidative damage to red blood cells in mice induced by arsine gas. Toxicology (1990) 0.82
Tolerance to cadmium-induced toxicity depends on presynthesized metallothionein in liver. J Toxicol Environ Health (1984) 0.81
Tolerance to cadmium-induced hepatotoxicity following cadmium pretreatment. Toxicol Appl Pharmacol (1984) 0.81
Resistance to cadmium-induced hepatotoxicity in immature rats. Toxicol Appl Pharmacol (1984) 0.81
The effects of acute and subacute sodium arsenite administration on carbohydrate metabolism. Toxicol Appl Pharmacol (1980) 0.81
Effect of intratracheal gallium arsenide administration on delta-aminolevulinic acid dehydratase in rats: relationship to urinary excretion of aminolevulinic acid. Toxicol Appl Pharmacol (1988) 0.81
Kidney zinc-thionein regulation of delta-aminolevulinic acid dehydratase inhibition by lead. Arch Biochem Biophys (1987) 0.81
Observations on the preparation of epoxy embedded tissue samples for energy-dispersive x-ray analysis. Stain Technol (1973) 0.81
Lead-binding proteins in brain tissue of environmentally lead-exposed humans. Chem Biol Interact (1995) 0.81
General subcellular effects of lead, mercury, cadmium, and arsenic. Environ Health Perspect (1978) 0.80
Zinc-induced tolerance to cadmium hepatotoxicity. Toxicol Appl Pharmacol (1984) 0.80
Arsine: absence of developmental toxicity in rats and mice. Fundam Appl Toxicol (1990) 0.80
Physiologically based pharmacokinetic (PBPK) tool kit for environmental pollutants--metals. SAR QSAR Environ Res (2010) 0.80
Mechanism of manganese-induced tolerance to cadmium lethality and hepatotoxicity. Biochem Pharmacol (1985) 0.80
Metal alteration of uroporphyrinogen decarboxylase and coproporphyrinogen oxidase. Ann N Y Acad Sci (1987) 0.80
The in vivo measurement of bone lead stores by 109Cd K X-ray fluorescence in a non-human primate (Macaca mulatta). Basic Life Sci (1993) 0.79
Intracellular metabolism and effects of circulating cadmium-metallothionein in the kidney. Environ Health Perspect (1984) 0.79
Altered regulation of mammalian hepatic heme biosynthesis and urinary porphyrin excretion during prolonged exposure to sodium arsenate. Toxicol Appl Pharmacol (1978) 0.79
Metal constitution of metallothionein influences inhibition of delta-aminolaevulinic acid dehydratase (porphobilinogen synthase) by lead. Biochem J (1987) 0.79
Studies on the mechanisms of thallium-mediated inhibition of hepatic mixed function oxidase activity. Correlation with inhibition of NADPH-cytochrome c (P-450) reductase. Biochem Pharmacol (1984) 0.79
The effects of prolonged oral arsenate exposure on liver mitochondria of mice: morphometric and biochemical studies. Toxicol Appl Pharmacol (1979) 0.79
Roles of metallothionein and related proteins in metal metabolism and toxicity: problems and perspectives. Environ Health Perspect (1986) 0.78
Alterations in the heme biosynthetic pathway from the III-V semiconductor metal, indium arsenide (InAs). Chem Biol Interact (1995) 0.78
Effects of lead inclusion bodies on subcellular distribution of lead in rat kidney: the relationship to mitochondrial function. Exp Mol Pathol (1985) 0.77
Phenobarbital protection against methyl mercury neophrotoxicity. Proc Soc Exp Biol Med (1975) 0.77
Induction of hepatic metallothionein in mouse liver following administration of chelating agents. Toxicol Appl Pharmacol (1985) 0.77
Relationship between metal toxicity to subcellular systems and the carcinogenic response. Environ Health Perspect (1981) 0.77
Biochemical and ultrastructural changes in livers of cadmium-treated rats. Toxicol Appl Pharmacol (1977) 0.77
Purification of invertebrate metallothioneins. Methods Enzymol (1991) 0.76
Altered regulation of hepatic heme metabolism by indium chloride. Toxicol Appl Pharmacol (1979) 0.76
Studies of hepatic mitochondrial structure and function: morphometric and biochemical evaluation of in vivo perturbation by arsenate. Lab Invest (1979) 0.76
Correlation of human hepatotoxicants with hepatic damage in animals. Fundam Appl Toxicol (1983) 0.76
Mechanism of cadmium-metallothionein-induced nephrotoxicity: relationship to altered renal calcium metabolism. Experientia Suppl (1987) 0.76
Lead accumulation by rat renal brush border membrane vesicles. J Pharmacol Exp Ther (1984) 0.76
Levels of toxic metals in marine organisms collected from Southern California coastal waters. Environ Health Perspect (1975) 0.75
International conference on environmental arsenic: an overview. Environ Health Perspect (1977) 0.75
Cytotoxicity, zinc protection, and stress protein induction in rat proximal tubule cells exposed to cadmium chloride in primary cell culture. Ren Fail (1996) 0.75